miR-874 suppresses the proliferation and metastasis of osteosarcoma by targeting E2F3

Dong Dong1, Yubao Gong2, Debao Zhang2

  • 1Department of Radiology, The First Hospital of Jilin University, No.71 Xinmin Street, Changchun, 130021, Jilin, China.

Insights

MicroRNA-874 (miR-874) is downregulated in osteosarcoma (OS). Restoring miR-874 inhibits OS cell proliferation and metastasis by targeting E2F transcription factor 3 (E2F3).

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are crucial in cancer development.
  • MicroRNA-874 (miR-874) is dysregulated in various cancers, but its role in osteosarcoma (OS) is unknown.

Purpose of the Study:

  • To investigate the function and mechanism of miR-874 in osteosarcoma.
  • To determine if miR-874 acts as a tumor suppressor in OS.

Main Methods:

  • Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) to assess miR-874 expression.
  • In vitro functional assays (proliferation, migration, invasion, apoptosis) in OS cells.
  • Western blot and luciferase assays to confirm E2F3 as a target of miR-874.

Main Results:

  • miR-874 expression was significantly decreased in OS tissues and cell lines.
  • miR-874 expression inversely correlated with tumor stage, size, and metastasis.
  • Overexpression of miR-874 inhibited OS cell proliferation, migration, and invasion, while promoting apoptosis.
  • E2F transcription factor 3 (E2F3) was identified as a direct target of miR-874.
  • Downregulation of E2F3 mimicked miR-874's tumor-suppressive effects; E2F3 overexpression partially reversed these effects.

Conclusions:

  • miR-874 functions as a tumor suppressor in osteosarcoma.
  • miR-874 inhibits OS cell growth and metastasis by targeting E2F3.
  • miR-874 represents a potential therapeutic target for osteosarcoma treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K